Cellect Biotechnology logo

APOP - Cellect Biotechnology News Story

$2.74 0.0  0.4%

Last Trade - 15/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £4.60m
Enterprise Value £84.6k
Revenue £n/a
Position in Universe 6086th / 6547

BRIEF-Cellect Biotechnology Reports Q1 Loss Per Share Of $0.002

Thu 21st May, 2020 9:51pm
May 21 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY REPORTS FIRST QUARTER 2020 FINANCIAL
AND
OPERATING RESULTS; CONTINUES TO DEMONSTRATE SIGNIFICANT PROGRESS
DESPITE ADJUSTED OPERATIONS DUE TO COVID-19
    * Q1 LOSS PER SHARE $0.002

Source text for Eikon:  ID:nPn1hv16Ba 
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.